US Dollar vs MXN

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
AMEX
Eagle Capital Growth Fund Inc (GRF)
Eagle Capital Growth Fund Inc (GRF) Noticias

GRF

Eagle Capital Growth (GRF)

Eagle Capital Growth Fund Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:GRF

1 2 3 4 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
18/04/2024	08:30	GlobeNewswire Inc.	Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.	AMEX:GRF	Eagle Capital Growth Fund Inc
04/04/2024	03:00	GlobeNewswire Inc.	Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Screening	AMEX:GRF	Eagle Capital Growth Fund Inc
07/03/2024	10:11	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	AMEX:GRF	Eagle Capital Growth Fund Inc
06/03/2024	11:56	Edgar (US Regulatory)	Form N-CSR - Certified Shareholder Report	AMEX:GRF	Eagle Capital Growth Fund Inc
28/02/2024	10:20	Edgar (US Regulatory)	Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)	AMEX:GRF	Eagle Capital Growth Fund Inc
23/02/2024	15:47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:GRF	Eagle Capital Growth Fund Inc
14/02/2024	02:16	GlobeNewswire Inc.	Grifols announces positive topline phase 3 fibrinogen clinical trial results	AMEX:GRF	Eagle Capital Growth Fund Inc
13/02/2024	14:09	Edgar (US Regulatory)	Form 5 - Annual statement of changes in beneficial ownership of securities	AMEX:GRF	Eagle Capital Growth Fund Inc
27/12/2023	14:58	Edgar (US Regulatory)	Form 40-17G - Fidelity Bond [Rule 17G-1(g)]	AMEX:GRF	Eagle Capital Growth Fund Inc
15/11/2023	07:00	GlobeNewswire Inc.	Grifols Completes Cohort 1 in Clinical Study of Alpha-1 15%, Evaluating First-in-Human Subcutaneous Dosing Option for Patients with Alpha1-Antitrypsin Deficiency	AMEX:GRF	Eagle Capital Growth Fund Inc
06/11/2023	07:00	GlobeNewswire Inc.	GigaGen Presents IND-Enabling Data and Phase 1 Trial Strategy for its Novel Anti-CTLA-4 Oncology Drug Candidate, GIGA-564, at SITC 2023	AMEX:GRF	Eagle Capital Growth Fund Inc
24/10/2023	17:30	GlobeNewswire Inc.	Araclon Biotech Presents Positive Final Results from Phase 2 Clinical Study of ABvac40 Alzheimer’s Vaccine at CTAD	AMEX:GRF	Eagle Capital Growth Fund Inc
13/10/2023	16:30	Business Wire	Eagle Capital Growth Fund Declares Year-End Distribution of $0.35 Per Share in Cash	AMEX:GRF	Eagle Capital Growth Fund Inc
02/10/2023	13:30	Edgar (US Regulatory)	Form SC 13D - General statement of acquisition of beneficial ownership	AMEX:GRF	Eagle Capital Growth Fund Inc
02/10/2023	13:16	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	AMEX:GRF	Eagle Capital Growth Fund Inc
15/08/2023	14:45	Edgar (US Regulatory)	Form N-CSRS - Certified Shareholder Report, Semi-Annual	AMEX:GRF	Eagle Capital Growth Fund Inc
01/08/2023	07:00	GlobeNewswire Inc.	Grifols Accelerates Healthcare Innovation with Google Cloud’s AI and Analytics	AMEX:GRF	Eagle Capital Growth Fund Inc
12/05/2023	12:28	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	AMEX:GRF	Eagle Capital Growth Fund Inc
12/05/2023	11:43	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:GRF	Eagle Capital Growth Fund Inc
19/04/2023	14:25	Edgar (US Regulatory)	Monthly Portfolio Investments Report on Form N-port (public) (nport-p)	AMEX:GRF	Eagle Capital Growth Fund Inc
18/04/2023	09:30	PR Newswire (US)	Grifols 2022 Annual Report on Form 20-F filed with the SEC on April 18, 2023	AMEX:GRF	Eagle Capital Growth Fund Inc
17/03/2023	08:40	Edgar (US Regulatory)	Certified Annual Shareholder Report for Management Investment Companies (n-csr)	AMEX:GRF	Eagle Capital Growth Fund Inc
01/03/2023	05:42	Edgar (US Regulatory)	Annual Report for Registered Investment Companies (n-cen)	AMEX:GRF	Eagle Capital Growth Fund Inc
14/02/2023	11:38	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	AMEX:GRF	Eagle Capital Growth Fund Inc
27/12/2022	13:03	Edgar (US Regulatory)	Fidelity Bond Filed Pursuant to Rule 17g-1(g)(1) of the Investment Company Act of 1940 (40-17g)	AMEX:GRF	Eagle Capital Growth Fund Inc
14/10/2022	16:00	Business Wire	Eagle Capital Growth Fund Declares Year-End Distribution of $0.37 Per Share in Cash	AMEX:GRF	Eagle Capital Growth Fund Inc
23/08/2022	13:02	Edgar (US Regulatory)	Certified Semi-annual Shareholder Report for Management Investment Companies (n-csrs)	AMEX:GRF	Eagle Capital Growth Fund Inc
12/05/2022	08:53	GlobeNewswire Inc.	Deutsche Bank’s Depositary Receipts Virtual Investor Conference presentations now available for on-demand viewing	AMEX:GRF	Eagle Capital Growth Fund Inc
05/05/2022	07:58	GlobeNewswire Inc.	International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 10th and 11th, 2022	AMEX:GRF	Eagle Capital Growth Fund Inc
01/04/2022	12:37	Edgar (US Regulatory)	Amended Certified Annual Shareholder Report for Management Investment Companies (n-csr/a)	AMEX:GRF	Eagle Capital Growth Fund Inc

Showing the most relevant articles for your search:AMEX:GRF

1 2 3 4 Próxima >

Bank of America

Health Care Select Sector

Invesco QQQ Trust Series 1

Financial Select Sector

Deutsche Telekom (QX)

Euro vs US Dollar

Energy Select Sector SPDR

American Express

US Dollar vs MXN

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones